🦊/People

Tom Miller

Founder

Founder at Iambic Therapeutics, Inc. · President of Issuer at Therabron Therapeutics · Co-Founder & CEO at Iambic

San Diego, California, United States

FoundedIambicIambic Therapeutics, Inc.

Find your path to Tom

400 people in our graph share verified history with Tom — schools, employers, funds. One of them is your warm intro.

Alice PillarunlockedTom: together at University of Oxford (2004–2005)
×7Tom: together at University of Oxford
Tom: together at UCL
Tom: together at UC Berkeley

About

Tom Miller, Ph.D., co-founded Iambic Therapeutics in 2020 and serves as its CEO, working at the intersection of AI, chemistry, and biology. Before Iambic, he spent over 10 years as a professor at the California Institute of Technology, where he received tenure and published more than 140 peer-reviewed articles and patents. Miller holds a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford, and he serves as an independent director at Veracyte (Nasdaq: VCYT).

Founder at Iambic Therapeutics, Inc.

Intro paths

In turn, Tom can intro founders to Iambic Therapeutics, Inc.'s investors below.

Co-founders at Iambic Therapeutics, Inc.

FM
Fred ManbyExecutive Officer, Director

President of Issuer at Therabron Therapeutics

Co-founders at Therabron Therapeutics

AL
Aprile L. Pilon-ClaytonChief Executive Officer and Director of Issuer
AP
Aprile Pilon-ClaytonExecutive Officer, Director, Promoter

Co-Founder & CEO at Iambic

Intro paths

In turn, Tom can intro founders to Iambic's investors below.

Co-founders at Iambic

FM
Fred ManbyCo-Founder & CTO
TMThomas Miller

Experience

  1. Iambic TherapeuticsCo-founder and CEOcurrent2020 — presentLa Jolla, California, United States
  2. Veracyte, Inc.Member Board of Directorscurrent2024 — present
  3. California Institute of TechnologyProfessor of Chemistry2013 — 2022
  4. California Institute of TechnologyAssistant Professor2008 — 2013
  5. UC BerkeleyPostdoctoral Fellow2005 — 2008

Skills & more

Spectroscopy32Physical Chemistry40Computational Chemistry27Molecular Dynamics20Quantum Chemistry20Nanotechnology19Theoretical Chemistry9Chemistry34High Performance Computing5molecular modeling7Scientific Computing18Monte Carlo Simulation7
+8 moreStatistical MechanicsBiophysicsNanomaterialsMolecular ModelingSimulationsResearchSciencePhysics

From Tom's professional profile.

Frequently asked questions

Who is Tom Miller?
Tom Miller, Ph.D., co-founded Iambic Therapeutics in 2020 and serves as its CEO, working at the intersection of AI, chemistry, and biology. Before Iambic, he spent over 10 years as a professor at the California Institute of Technology, where he received tenure and published more than 140 peer-reviewed articles and patents. Miller holds a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford, and he serves as an independent director at Veracyte (Nasdaq: VCYT).
Where does Tom Miller work?
Tom Miller is Founder of Iambic and Co-founder at Iambic Therapeutics, Inc. and President of Issuer at Therabron Therapeutics.
What companies did Tom Miller found?
Tom Miller founded Iambic, Iambic Therapeutics, Inc..
Where did Tom Miller go to school?
Tom Miller studied at University of Oxford (Doctor of Philosophy (Ph.D.), Theoretical Chemistry); UCL (Master of Philosophy (M.Phil.), Theoretical Chemistry); Texas A&M University (Bachelor of Science (B.S.), Chemistry and Mathematics).

Founder mafias

Same school

Shared employers